欧盟EMA药品数据库-欧盟集中审批药品
(European Medicines Agency Authorisation of Medicines DataBase)
商品名称 适用类别 通用名称 活性成分 产品号 上市许可开发者/申请人/持有人 上市许可日期 许可状态
Pedea Human ibuprofen Ibuprofen EMEA/H/C/000549 Recordati Rare Diseases 2004/07/28 Authorised
Telzir Human fosamprenavir fosamprenavir calcium EMEA/H/C/000534 ViiV Healthcare BV 2004/07/12 Withdrawn
Lyrica Human pregabalin pregabalin EMEA/H/C/000546 Upjohn EESV 2004/07/05 Authorised
Erbitux Human cetuximab cetuximab EMEA/H/C/000558 Merck Europe B.V.  2004/06/29 Authorised
Kentera (previously Oxybutynin Nicobrand) Human oxybutynin oxybutynin EMEA/H/C/000532 Teva B.V.  2004/06/15 Authorised
TachoSil Human human fibrinogen;human thrombin human fibrinogen;human thrombin EMEA/H/C/000505 Corza Medical GmbH 2004/06/08 Authorised
Abilify Human aripiprazole aripiprazole EMEA/H/C/000471 Otsuka Pharmaceutical Netherlands B.V. 2004/06/04 Authorised
Levemir Human insulin detemir Insulin detemir EMEA/H/C/000528 Novo Nordisk A/S 2004/06/01 Authorised
Lysodren Human mitotane mitotane EMEA/H/C/000521 Esteve Pharmaceuticals, S.A. 2004/04/28 Authorised
Dukoral Human cholera vaccine (inactivated, oral) recombinant cholera toxin B subunit;vibrio cholerae 01 EMEA/H/C/000476 Valneva Sweden AB 2004/04/28 Authorised
Velcade Human bortezomib bortezomib EMEA/H/C/000539 Janssen-Cilag International NV 2004/04/26 Authorised
Litak Human cladribine cladribine EMEA/H/C/000504 Lipomed GmbH 2004/04/14 Authorised
PhotoBarr Human porfimer sodium porfimer sodium EMEA/H/C/000493 Pinnacle Biologics B.V.  2004/03/25 Withdrawn
Cholestagel Human colesevelam colesevelam (as hydrochloride) EMEA/H/C/000512 CHEPLAPHARM Arzneimittel GmbH 2004/03/09 Authorised
Faslodex Human fulvestrant fulvestrant EMEA/H/C/000540 AstraZeneca AB 2004/03/09 Authorised
Advate Human octocog alfa octocog alfa EMEA/H/C/000520 Takeda Manufacturing Austria AG 2004/03/02 Authorised
Reyataz Human atazanavir sulfate atazanavir (as sulfate) EMEA/H/C/000494 Bristol-Myers Squibb Pharma EEIG 2004/03/01 Authorised
Bonviva Human ibandronic acid ibandronic acid EMEA/H/C/000501 Atnahs Pharma Netherlands B.V. 2004/02/23 Authorised
Bondenza (previously Ibandronic Acid Roche) Human ibandronic acid ibandronic acid EMEA/H/C/000502 Roche Registration Ltd. 2004/02/23 Withdrawn
Zevalin Human ibritumomab tiuxetan ibritumomab tiuxetan EMEA/H/C/000547 Ceft Biopharma s.r.o. 2004/01/16 Lapsed

数据库说明:

©2006-2026 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase